X4制药(XFOR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

XFOR X4制药

交易中 01-14 11:48:57 EST

3.87

+0.00

+0.08%

最高3.92	最低3.82	成交量6.80万
今开3.87	昨收3.87	日振幅2.45%
总市值3.39亿	流通市值2.69亿	总股本8,744万
成交额26.29万	换手率0.10%	流通股本6,955万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"XFOR","market":"US","secType":"STK","nameCN":"X4制药","latestPrice":3.873,"timestamp":1768409281804,"preClose":3.87,"halted":0,"volume":68036,"delay":0,"changeRate":0.0007751937984496418,"floatShares":69550600,"shares":87436700,"eps":-10.5034,"marketStatus":"交易中","change":0.003,"latestTime":"01-14 11:48:57 EST","open":3.87,"high":3.915,"low":3.82,"amount":262931.4969732,"amplitude":0.024548,"askPrice":3.88,"askSize":138,"bidPrice":3.87,"bidSize":399,"shortable":3,"etf":0,"ttmEps":-10.5034,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1768424400000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1510808400000,"exchange":"NASDAQ","adjPreClose":3.87,"preHourTrading":{"tag":"盘前","latestPrice":3.86,"preClose":3.87,"latestTime":"08:18 EST","volume":40,"amount":154.4,"timestamp":1768396738246},"postHourTrading":{"tag":"盘后","latestPrice":3.87,"preClose":3.87,"latestTime":"19:04 EST","volume":1365,"amount":5281.95,"timestamp":1768349047297},"volumeRatio":0.373398,"impliedVol":0.72,"impliedVolPercentile":0.662},"requestUrl":"/m/hq/s/XFOR","defaultTab":"news","newsList":[{"id":"2595756766","title":"X4制药盘中异动 急速下挫5.33%报4.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2595756766","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595756766?lang=zh_cn&edition=full","pubTime":"2025-12-30 02:21","pubTimestamp":1767032484,"startTime":"0","endTime":"0","summary":"北京时间2025年12月30日02时21分，X4制药股票出现波动，股价快速跳水5.33%。截至发稿，该股报4.26美元/股，成交量14.1842万股，换手率0.16%，振幅4.11%。机构评级方面，在所有4家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。X4制药股票所在的生物技术行业中，整体跌幅为0.62%。公司还有两种临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230022124a486fc8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230022124a486fc8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XFOR","BK4139"],"gpt_icon":0},{"id":"2569775920","title":"X4制药盘中异动 早盘大幅拉升5.05%报3.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2569775920","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569775920?lang=zh_cn&edition=full","pubTime":"2025-09-22 22:43","pubTimestamp":1758552217,"startTime":"0","endTime":"0","summary":"北京时间2025年09月22日22时43分，X4制药股票出现波动，股价快速拉升5.05%。截至发稿，该股报3.33美元/股，成交量8.6009万股，换手率0.38%，振幅6.62%。机构评级方面，在所有4家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。X4制药股票所在的生物技术行业中，整体涨幅为0.66%。公司还有两种临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092222433797a2a0f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092222433797a2a0f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XFOR","BK4139"],"gpt_icon":0},{"id":"2568249976","title":"X4制药将裁员50% 多名高管将离职","url":"https://stock-news.laohu8.com/highlight/detail?id=2568249976","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568249976?lang=zh_cn&edition=full","pubTime":"2025-09-17 21:12","pubTimestamp":1758114756,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["XFOR","BK4139"],"gpt_icon":0},{"id":"1188959045","title":"X4制药：作为裁员计划的一部分，首席运营官Mary Dibiase将离开公司","url":"https://stock-news.laohu8.com/highlight/detail?id=1188959045","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188959045?lang=zh_cn&edition=full","pubTime":"2025-09-17 19:09","pubTimestamp":1758107353,"startTime":"0","endTime":"0","summary":"X4制药宣布，作为裁员计划的一部分，公司首席运营官Mary Dibiase将离开公司。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","XFOR"],"gpt_icon":0},{"id":"1132371771","title":"X4 Pharmaceuticals宣布重组业务运营以推动长期价值创造","url":"https://stock-news.laohu8.com/highlight/detail?id=1132371771","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132371771?lang=zh_cn&edition=full","pubTime":"2025-09-17 19:01","pubTimestamp":1758106901,"startTime":"0","endTime":"0","summary":"X4 Pharmaceuticals宣布重组业务运营以推动长期价值创造","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XFOR","BK4139"],"gpt_icon":0},{"id":"2566936924","title":"X4制药盘中异动 大幅跳水5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2566936924","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566936924?lang=zh_cn&edition=full","pubTime":"2025-09-11 21:34","pubTimestamp":1757597642,"startTime":"0","endTime":"0","summary":"北京时间2025年09月11日21时34分，X4制药股票出现异动，股价急速下挫5.30%。截至发稿，该股报3.21美元/股，成交量3.524万股，换手率0.16%，振幅1.22%。机构评级方面，在所有4家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。X4制药股票所在的生物技术行业中，整体涨幅为0.42%。公司还有两种临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250911213402a4c11d32&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250911213402a4c11d32&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XFOR"],"gpt_icon":0},{"id":"1153246602","title":"X4制药向SEC提交文件，申请由股东出售最多5990万股普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1153246602","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153246602?lang=zh_cn&edition=full","pubTime":"2025-09-11 04:19","pubTimestamp":1757535559,"startTime":"0","endTime":"0","summary":"X4制药(X4 Pharmaceuticals Inc)向SEC提交文件，申请由出售股东发售最多5990万股普通股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","XFOR"],"gpt_icon":0},{"id":"2563095055","title":"X4制药盘中异动 股价大跌5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2563095055","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563095055?lang=zh_cn&edition=full","pubTime":"2025-08-29 00:03","pubTimestamp":1756397006,"startTime":"0","endTime":"0","summary":"北京时间2025年08月29日00时03分，X4制药股票出现波动，股价快速下挫5.20%。截至发稿，该股报4.01美元/股，成交量32.4352万股，换手率1.44%，振幅8.43%。机构评级方面，在所有3家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。X4制药股票所在的生物技术行业中，整体涨幅为0.04%。公司还有两种临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250829000326a4a58f3e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250829000326a4a58f3e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OR","XFOR","BK4139","BK4017"],"gpt_icon":0},{"id":"2558651986","title":"X4制药盘中异动 大幅下挫6.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558651986","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558651986?lang=zh_cn&edition=full","pubTime":"2025-08-11 21:34","pubTimestamp":1754919280,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日21时34分，X4制药股票出现异动，股价急速下挫6.04%。截至发稿，该股报1.40美元/股，成交量15.1112万股，换手率2.10%，振幅3.36%。机构评级方面，在所有3家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。X4制药股票所在的生物技术行业中，整体跌幅为0.19%。公司还有两种临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811213441a6dfb97c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811213441a6dfb97c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XFOR"],"gpt_icon":0},{"id":"2557598332","title":"X4制药盘中异动 下午盘股价大跌5.06%报1.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557598332","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557598332?lang=zh_cn&edition=full","pubTime":"2025-08-08 01:04","pubTimestamp":1754586295,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日01时04分，X4制药股票出现波动，股价急速跳水5.06%。截至发稿，该股报1.50美元/股，成交量39.8354万股，换手率5.55%，振幅8.22%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。X4制药股票所在的生物技术行业中，整体跌幅为0.15%。公司还有两种临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808010455a47b6fd9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808010455a47b6fd9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XFOR","BK4139"],"gpt_icon":0},{"id":"2557132370","title":"X4制药盘中异动 股价大涨6.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557132370","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557132370?lang=zh_cn&edition=full","pubTime":"2025-08-06 21:30","pubTimestamp":1754487037,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日21时30分，X4制药股票出现波动，股价快速拉升6.34%。截至发稿，该股报1.71美元/股，成交量23.166万股，换手率3.23%，振幅0.00%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。X4制药股票所在的生物技术行业中，整体涨幅为0.00%。X4制药公司简介：X4 Pharmaceuticals Inc 是一家生物制药公司，开发和商业化用于治疗罕见免疫系统疾病的新疗法。公司还有两种临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806213037a478d766&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806213037a478d766&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XFOR"],"gpt_icon":0},{"id":"2556817382","title":"X4制药盘中异动 早盘大幅跳水5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556817382","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556817382?lang=zh_cn&edition=full","pubTime":"2025-08-01 21:32","pubTimestamp":1754055132,"startTime":"0","endTime":"0","summary":"北京时间2025年08月01日21时32分，X4制药股票出现波动，股价快速下跌5.36%。截至发稿，该股报1.59美元/股，成交量9.799万股，换手率1.36%，振幅2.38%。X4制药股票所在的生物技术行业中，整体涨幅为0.52%。X4制药公司简介：X4 Pharmaceuticals Inc 是一家生物制药公司，开发和商业化用于治疗罕见免疫系统疾病的新疗法。公司还有两种临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801213212a6cdeb5f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801213212a6cdeb5f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XFOR"],"gpt_icon":0},{"id":"2555620052","title":"X4制药盘中异动 大幅下挫5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555620052","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555620052?lang=zh_cn&edition=full","pubTime":"2025-07-29 21:45","pubTimestamp":1753796702,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日21时45分，X4制药股票出现异动，股价快速下挫5.16%。截至发稿，该股报2.02美元/股，成交量44.0198万股，换手率6.13%，振幅6.18%。X4制药股票所在的生物技术行业中，整体涨幅为0.09%。X4制药公司简介：X4 Pharmaceuticals Inc 是一家生物制药公司，开发和商业化用于治疗罕见免疫系统疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072921450297258af7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072921450297258af7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XFOR"],"gpt_icon":0},{"id":"2554777201","title":"X4制药盘中异动 急速上涨5.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554777201","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554777201?lang=zh_cn&edition=full","pubTime":"2025-07-28 21:30","pubTimestamp":1753709436,"startTime":"0","endTime":"0","summary":"北京时间2025年07月28日21时30分，X4制药股票出现异动，股价快速拉升5.49%。截至发稿，该股报1.92美元/股，成交量11.3982万股，换手率1.59%，振幅1.59%。X4制药股票所在的生物技术行业中，整体涨幅为0.00%。X4制药公司简介：X4 Pharmaceuticals Inc 是一家生物制药公司，开发和商业化用于治疗罕见免疫系统疾病的新疗法。公司还有两种临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728213036a467d8ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728213036a467d8ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XFOR","BK4139"],"gpt_icon":0},{"id":"2551129702","title":"X4制药盘中异动 股价大涨5.44%报1.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551129702","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551129702?lang=zh_cn&edition=full","pubTime":"2025-07-16 21:40","pubTimestamp":1752673212,"startTime":"0","endTime":"0","summary":"北京时间2025年07月16日21时40分，X4制药股票出现波动，股价急速上涨5.44%。截至发稿，该股报1.55美元/股，成交量9.4787万股，换手率1.32%，振幅2.72%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。X4制药股票所在的生物技术行业中，整体涨幅为0.76%。公司还有两种临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716214012a6ada494&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716214012a6ada494&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XFOR"],"gpt_icon":0},{"id":"2550678424","title":"X4制药盘中异动 下午盘急速跳水5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550678424","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550678424?lang=zh_cn&edition=full","pubTime":"2025-07-11 02:27","pubTimestamp":1752172070,"startTime":"0","endTime":"0","summary":"北京时间2025年07月11日02时27分，X4制药股票出现波动，股价快速下跌5.12%。截至发稿，该股报1.58美元/股，成交量37.9409万股，换手率5.29%，振幅9.03%。X4制药股票所在的生物技术行业中，整体涨幅为0.77%。X4制药公司简介：X4 Pharmaceuticals Inc 是一家生物制药公司，开发和商业化用于治疗罕见免疫系统疾病的新疗法。公司还有两种临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711022750953dbf8c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711022750953dbf8c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XFOR","BK4139"],"gpt_icon":0},{"id":"2550656057","title":"X4制药盘中异动 股价大涨6.31%报1.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550656057","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550656057?lang=zh_cn&edition=full","pubTime":"2025-07-09 21:32","pubTimestamp":1752067966,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日21时32分，X4制药股票出现波动，股价大幅拉升6.31%。截至发稿，该股报1.77美元/股，成交量9751股，换手率0.14%，振幅0.00%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。X4制药股票所在的生物技术行业中，整体涨幅为0.59%。X4制药公司简介：X4 Pharmaceuticals Inc 是一家生物制药公司，开发和商业化用于治疗罕见免疫系统疾病的新疗法。公司还有两种临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709213246a69f8cae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709213246a69f8cae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XFOR","BK4139"],"gpt_icon":0},{"id":"2549620555","title":"X4制药盘中异动 早盘股价大跌5.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549620555","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549620555?lang=zh_cn&edition=full","pubTime":"2025-07-07 22:56","pubTimestamp":1751900178,"startTime":"0","endTime":"0","summary":"北京时间2025年07月07日22时56分，X4制药股票出现波动，股价快速跳水5.82%。截至发稿，该股报1.78美元/股，成交量13.3786万股，换手率1.86%，振幅6.83%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。X4制药股票所在的生物技术行业中，整体跌幅为0.27%。X4制药公司简介：X4 Pharmaceuticals Inc 是一家生物制药公司，开发和商业化用于治疗罕见免疫系统疾病的新疗法。公司还有两种临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707225619a43c155b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707225619a43c155b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XFOR"],"gpt_icon":0},{"id":"2518271968","title":"X4制药盘中异动 早盘急速跳水5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518271968","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518271968?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:36","pubTimestamp":1741617417,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时36分，X4制药股票出现波动，股价急速下跌5.09%。截至发稿，该股报0.334美元/股，成交量23.015万股，换手率0.13%，振幅5.57%。机构评级方面，在所有5家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。X4制药股票所在的生物技术行业中，整体涨幅为0.02%。它还拥有两个临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310223658a26a3dd0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310223658a26a3dd0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XFOR","BK4139"],"gpt_icon":0},{"id":"2517360507","title":"X4制药盘中异动 急速下挫5.00%报0.342美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517360507","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517360507?lang=zh_cn&edition=full","pubTime":"2025-03-04 23:53","pubTimestamp":1741103595,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日23时53分，X4制药股票出现异动，股价大幅下跌5.00%。截至发稿，该股报0.342美元/股，成交量58.3037万股，换手率0.34%，振幅6.02%。机构评级方面，在所有5家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。X4制药股票所在的生物技术行业中，整体跌幅为0.21%。它还拥有两个临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304235315989bc18b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304235315989bc18b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XFOR"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.x4pharma.com","stockEarnings":[{"period":"1week","weight":-0.0227},{"period":"1month","weight":-0.0102},{"period":"3month","weight":0.3531},{"period":"6month","weight":1.5973},{"period":"1year","weight":-0.7718},{"period":"ytd","weight":-0.0325}],"compareEarnings":[{"period":"1week","weight":0.0028},{"period":"1month","weight":0.0176},{"period":"3month","weight":0.043},{"period":"6month","weight":0.1047},{"period":"1year","weight":0.1933},{"period":"ytd","weight":0.0174}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"X4 Pharmaceuticals, Inc.于2010年8月2日根据特拉华州法律注册成立。该公司是一家晚期临床阶段的生物制药公司，发现和开发用于治疗罕见疾病和治疗选择有限的疾病的新疗法，重点关注免疫系统功能障碍导致的疾病。该公司的主要临床候选药物是mavorixafor，这是一种趋化因子受体CXCR4的小分子选择性拮抗剂，正在开发为一种口服、每日一次的疗法。由于mavorixafor能够增加成熟、功能性白细胞进入血液的动员，该公司认为mavorixafor有可能在多种慢性中性粒细胞减少症中提供治疗益处，包括WHIM（疣、低丙种球蛋白血症、感染和骨髓松弛症）综合征，这是一种罕见的原发性免疫缺陷。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.006017},{"month":2,"riseRate":0.625,"avgChangeRate":0.017263},{"month":3,"riseRate":0.5,"avgChangeRate":0.070477},{"month":4,"riseRate":0.25,"avgChangeRate":-0.02608},{"month":5,"riseRate":0.25,"avgChangeRate":-0.040791},{"month":6,"riseRate":0.125,"avgChangeRate":-0.268932},{"month":7,"riseRate":0.25,"avgChangeRate":-0.039863},{"month":8,"riseRate":0.375,"avgChangeRate":0.07504},{"month":9,"riseRate":0.25,"avgChangeRate":-0.001382},{"month":10,"riseRate":0.25,"avgChangeRate":-0.084011},{"month":11,"riseRate":0.25,"avgChangeRate":0.161316},{"month":12,"riseRate":0.444444,"avgChangeRate":-0.049964}],"exchange":"NASDAQ","name":"X4制药","nameEN":"X4 Pharmaceuticals Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"X4制药(XFOR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供X4制药(XFOR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"X4制药,XFOR,X4制药股票,X4制药股票老虎,X4制药股票老虎国际,X4制药行情,X4制药股票行情,X4制药股价,X4制药股市,X4制药股票价格,X4制药股票交易,X4制药股票购买,X4制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"X4制药(XFOR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供X4制药(XFOR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}